Header Logo

Connection

TERZAH HORTON to Transcription Factor RelA

Back to Details
This is a "connection" page, showing publications TERZAH HORTON has written about Transcription Factor RelA.
TERZAH HORTON
Connection Strength
0.183
Transcription Factor RelA
  1. Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-?B subunit RelA. Proteomics Clin Appl. 2022 03; 16(2):e2100072.
    View in: PubMed
    Score: 0.183
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.